In the present pandemic time, face masks are found to be the most effective strategy against the spread of the virus within the community. As aerosol-based spreading of the virus is considered as the primary mode of transmission, the interaction of masks with incoming droplets needs to be understood thoroughly for an effective usage among the public. In the present work, we explore the interactions of the droplets over the most commonly used 3-ply surgical masks. A detailed study of the wetting signature, adhesion, and impact dynamics of water droplets and microbe-laden droplets is carried out for both sides of the mask. We found that the interfacial characteristics of the incoming droplets with the mask are very similar for the front and the back side of the mask. Further, in an anticipated attempt to reduce the adhesion, we have tested masks with a superhydrophobic coating. It is found that a superhydrophobic coating may not be the best choice for a regular mask as it can give rise to a number of smaller daughter droplets that can linger in air for longer times and can contribute to the transmission of potential viral loads.

3D in vitro biological systems are progressively replacing 2D systems to increase the physiological relevance of cellular studies. Microfluidics-based approaches can be powerful tools towards such biomimetic systems, but often require high-end complicated and expensive processes and equipment for microfabrication. Herein, a drug screening platform is proposed, minimizing technicality and manufacturing steps. It provides an alternate way of spheroid generation in droplets in tubes. Droplets microfluidics then elicit multiple droplets merging events at programmable times, to submit sequentially the spheroids to chemotherapy and to reagents for cytotoxicity screening. After a comprehensive study of tumorigenesis within the droplets, the system is validated for drug screening (IC50) with chemotherapies in cancer cell lines as well as cells from patient-derived-xenografts (PDX). As compared to microtiter plates methods, our system reduces the initial amount of cell up to 10 times and opens new avenues towards primary tumors drug screening approaches.